世界の慢性特発性骨髄線維症市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chronic Idiopathic Myelofibrosis Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1315 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、慢性特発性骨髄線維症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、生物学的療法、その他）、用途別市場規模（病院、クリニック、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・慢性特発性骨髄線維症の市場動向 ・企業の競争状況、市場シェア ・慢性特発性骨髄線維症の種類別市場規模（化学療法、生物学的療法、その他） ・慢性特発性骨髄線維症の用途別市場規模（病院、クリニック、研究機関） ・慢性特発性骨髄線維症の北米市場規模2016-2027（アメリカ、カナダ） ・慢性特発性骨髄線維症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・慢性特発性骨髄線維症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・慢性特発性骨髄線維症の中南米市場規模2016-2027（メキシコ、ブラジル） ・慢性特発性骨髄線維症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（S-BIO、YM BioSciences、Sanofi、Onyx Pharmaceuticals） ・結論

Idiopathic myelofibrosis is a chronic myelo-proliferative disorder and characterized by abnormal mutation of stem cells. This abnormal mutation of stem cells and excessive production of platelets result in development of fibrous tissues within the bone-marrow. This factor would ultimately negatively affect on the development of white blood cells (WBCs), red blood cells (RBCs) and platelets. The condition of idiopathic myelofibrosis may ultimately lead to the risk of acute myelogenous leukemia. Risk of idiopathic myelofibrosis is more in geriatric population as compared to children and adult population. Patients may develop symptoms such as weakness, weight loss, night sweats, hypertension and others. Blood chemistry tests, bone marrow aspiration, molecular testing and biopsy are useful diagnostic tools to diagnose and detect chronic idiopathic myelofibrosis. Patients with idiopathic myelofibrosis are advised to take drugs like hydroxyurea, interferon alfa, androgens, prednisone and others in order to treat this disorder. In addition, stem cell transplant and splenectomy is performed by physicians in severe cases of chronic idiopathic myelofibrosis.
The market of chronic idiopathic myelofibrosis is majorly driven by consistent efforts of key players to develop new and effective therapeutics. In addition, strategic collaboration and acquisition adopted by key players will further act as a driving factor for this market.

Market Analysis and Insights: Global Chronic Idiopathic Myelofibrosis Market
The global Chronic Idiopathic Myelofibrosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Idiopathic Myelofibrosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Idiopathic Myelofibrosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Idiopathic Myelofibrosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Idiopathic Myelofibrosis market.

Global Chronic Idiopathic Myelofibrosis Scope and Market Size
Chronic Idiopathic Myelofibrosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Idiopathic Myelofibrosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Biological Therapy
Others

Segment by Application
Hospitals
Clinics
Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
S-BIO
YM BioSciences
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Idiopathic Myelofibrosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Biological Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Chronic Idiopathic Myelofibrosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chronic Idiopathic Myelofibrosis Market Perspective (2016-2027)
2.2 Chronic Idiopathic Myelofibrosis Growth Trends by Regions
2.2.1 Chronic Idiopathic Myelofibrosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Idiopathic Myelofibrosis Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Idiopathic Myelofibrosis Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Idiopathic Myelofibrosis Industry Dynamic
2.3.1 Chronic Idiopathic Myelofibrosis Market Trends
2.3.2 Chronic Idiopathic Myelofibrosis Market Drivers
2.3.3 Chronic Idiopathic Myelofibrosis Market Challenges
2.3.4 Chronic Idiopathic Myelofibrosis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chronic Idiopathic Myelofibrosis Players by Revenue
3.1.1 Global Top Chronic Idiopathic Myelofibrosis Players by Revenue (2016-2021)
3.1.2 Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Idiopathic Myelofibrosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Idiopathic Myelofibrosis Revenue
3.4 Global Chronic Idiopathic Myelofibrosis Market Concentration Ratio
3.4.1 Global Chronic Idiopathic Myelofibrosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Idiopathic Myelofibrosis Revenue in 2020
3.5 Chronic Idiopathic Myelofibrosis Key Players Head office and Area Served
3.6 Key Players Chronic Idiopathic Myelofibrosis Product Solution and Service
3.7 Date of Enter into Chronic Idiopathic Myelofibrosis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Idiopathic Myelofibrosis Breakdown Data by Type
4.1 Global Chronic Idiopathic Myelofibrosis Historic Market Size by Type (2016-2021)
4.2 Global Chronic Idiopathic Myelofibrosis Forecasted Market Size by Type (2022-2027)

5 Chronic Idiopathic Myelofibrosis Breakdown Data by Application
5.1 Global Chronic Idiopathic Myelofibrosis Historic Market Size by Application (2016-2021)
5.2 Global Chronic Idiopathic Myelofibrosis Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chronic Idiopathic Myelofibrosis Market Size (2016-2027)
6.2 North America Chronic Idiopathic Myelofibrosis Market Size by Type
6.2.1 North America Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2021)
6.2.2 North America Chronic Idiopathic Myelofibrosis Market Size by Type (2022-2027)
6.2.3 North America Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2027)
6.3 North America Chronic Idiopathic Myelofibrosis Market Size by Application
6.3.1 North America Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2021)
6.3.2 North America Chronic Idiopathic Myelofibrosis Market Size by Application (2022-2027)
6.3.3 North America Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2027)
6.4 North America Chronic Idiopathic Myelofibrosis Market Size by Country
6.4.1 North America Chronic Idiopathic Myelofibrosis Market Size by Country (2016-2021)
6.4.2 North America Chronic Idiopathic Myelofibrosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Chronic Idiopathic Myelofibrosis Market Size (2016-2027)
7.2 Europe Chronic Idiopathic Myelofibrosis Market Size by Type
7.2.1 Europe Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2021)
7.2.2 Europe Chronic Idiopathic Myelofibrosis Market Size by Type (2022-2027)
7.2.3 Europe Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2027)
7.3 Europe Chronic Idiopathic Myelofibrosis Market Size by Application
7.3.1 Europe Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2021)
7.3.2 Europe Chronic Idiopathic Myelofibrosis Market Size by Application (2022-2027)
7.3.3 Europe Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2027)
7.4 Europe Chronic Idiopathic Myelofibrosis Market Size by Country
7.4.1 Europe Chronic Idiopathic Myelofibrosis Market Size by Country (2016-2021)
7.4.2 Europe Chronic Idiopathic Myelofibrosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size (2016-2027)
8.2 Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Type
8.2.1 Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Application
8.3.1 Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Region
8.4.1 Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chronic Idiopathic Myelofibrosis Market Size (2016-2027)
9.2 Latin America Chronic Idiopathic Myelofibrosis Market Size by Type
9.2.1 Latin America Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Idiopathic Myelofibrosis Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2027)
9.3 Latin America Chronic Idiopathic Myelofibrosis Market Size by Application
9.3.1 Latin America Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Idiopathic Myelofibrosis Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2027)
9.4 Latin America Chronic Idiopathic Myelofibrosis Market Size by Country
9.4.1 Latin America Chronic Idiopathic Myelofibrosis Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Idiopathic Myelofibrosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size (2016-2027)
10.2 Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Type
10.2.1 Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Application
10.3.1 Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Country
10.4.1 Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 S-BIO
11.1.1 S-BIO Company Details
11.1.2 S-BIO Business Overview
11.1.3 S-BIO Chronic Idiopathic Myelofibrosis Introduction
11.1.4 S-BIO Revenue in Chronic Idiopathic Myelofibrosis Business (2016-2021)
11.1.5 S-BIO Recent Development
11.2 YM BioSciences
11.2.1 YM BioSciences Company Details
11.2.2 YM BioSciences Business Overview
11.2.3 YM BioSciences Chronic Idiopathic Myelofibrosis Introduction
11.2.4 YM BioSciences Revenue in Chronic Idiopathic Myelofibrosis Business (2016-2021)
11.2.5 YM BioSciences Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Chronic Idiopathic Myelofibrosis Introduction
11.3.4 Sanofi Revenue in Chronic Idiopathic Myelofibrosis Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Onyx Pharmaceuticals
11.4.1 Onyx Pharmaceuticals Company Details
11.4.2 Onyx Pharmaceuticals Business Overview
11.4.3 Onyx Pharmaceuticals Chronic Idiopathic Myelofibrosis Introduction
11.4.4 Onyx Pharmaceuticals Revenue in Chronic Idiopathic Myelofibrosis Business (2016-2021)
11.4.5 Onyx Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Idiopathic Myelofibrosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Biological Therapy
Table 4. Key Players of Others
Table 5. Global Chronic Idiopathic Myelofibrosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chronic Idiopathic Myelofibrosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chronic Idiopathic Myelofibrosis Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Chronic Idiopathic Myelofibrosis Market Share by Regions (2016-2021)
Table 9. Global Chronic Idiopathic Myelofibrosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Chronic Idiopathic Myelofibrosis Market Share by Regions (2022-2027)
Table 11. Chronic Idiopathic Myelofibrosis Market Trends
Table 12. Chronic Idiopathic Myelofibrosis Market Drivers
Table 13. Chronic Idiopathic Myelofibrosis Market Challenges
Table 14. Chronic Idiopathic Myelofibrosis Market Restraints
Table 15. Global Chronic Idiopathic Myelofibrosis Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Chronic Idiopathic Myelofibrosis Market Share by Players (2016-2021)
Table 17. Global Top Chronic Idiopathic Myelofibrosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Idiopathic Myelofibrosis as of 2020)
Table 18. Ranking of Global Top Chronic Idiopathic Myelofibrosis Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Chronic Idiopathic Myelofibrosis Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Chronic Idiopathic Myelofibrosis Product Solution and Service
Table 22. Date of Enter into Chronic Idiopathic Myelofibrosis Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Type (2016-2021)
Table 26. Global Chronic Idiopathic Myelofibrosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Chronic Idiopathic Myelofibrosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Application (2016-2021)
Table 30. Global Chronic Idiopathic Myelofibrosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Chronic Idiopathic Myelofibrosis Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Chronic Idiopathic Myelofibrosis Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Chronic Idiopathic Myelofibrosis Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Chronic Idiopathic Myelofibrosis Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Chronic Idiopathic Myelofibrosis Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Chronic Idiopathic Myelofibrosis Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Chronic Idiopathic Myelofibrosis Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Chronic Idiopathic Myelofibrosis Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Chronic Idiopathic Myelofibrosis Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Chronic Idiopathic Myelofibrosis Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Chronic Idiopathic Myelofibrosis Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Chronic Idiopathic Myelofibrosis Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size by Country (2022-2027) & (US$ Million)
Table 62. S-BIO Company Details
Table 63. S-BIO Business Overview
Table 64. S-BIO Chronic Idiopathic Myelofibrosis Product
Table 65. S-BIO Revenue in Chronic Idiopathic Myelofibrosis Business (2016-2021) & (US$ Million)
Table 66. S-BIO Recent Development
Table 67. YM BioSciences Company Details
Table 68. YM BioSciences Business Overview
Table 69. YM BioSciences Chronic Idiopathic Myelofibrosis Product
Table 70. YM BioSciences Revenue in Chronic Idiopathic Myelofibrosis Business (2016-2021) & (US$ Million)
Table 71. YM BioSciences Recent Development
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Chronic Idiopathic Myelofibrosis Product
Table 75. Sanofi Revenue in Chronic Idiopathic Myelofibrosis Business (2016-2021) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Onyx Pharmaceuticals Company Details
Table 78. Onyx Pharmaceuticals Business Overview
Table 79. Onyx Pharmaceuticals Chronic Idiopathic Myelofibrosis Product
Table 80. Onyx Pharmaceuticals Revenue in Chronic Idiopathic Myelofibrosis Business (2016-2021) & (US$ Million)
Table 81. Onyx Pharmaceuticals Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Idiopathic Myelofibrosis Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Biological Therapy Features
Figure 4. Others Features
Figure 5. Global Chronic Idiopathic Myelofibrosis Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Chronic Idiopathic Myelofibrosis Report Years Considered
Figure 10. Global Chronic Idiopathic Myelofibrosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Chronic Idiopathic Myelofibrosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Chronic Idiopathic Myelofibrosis Market Share by Regions: 2020 VS 2027
Figure 13. Global Chronic Idiopathic Myelofibrosis Market Share by Regions (2022-2027)
Figure 14. Global Chronic Idiopathic Myelofibrosis Market Share by Players in 2020
Figure 15. Global Top Chronic Idiopathic Myelofibrosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Idiopathic Myelofibrosis as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Chronic Idiopathic Myelofibrosis Revenue in 2020
Figure 17. Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Type (2016-2021)
Figure 18. Global Chronic Idiopathic Myelofibrosis Revenue Market Share by Type (2022-2027)
Figure 19. North America Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Chronic Idiopathic Myelofibrosis Market Share by Type (2016-2027)
Figure 21. North America Chronic Idiopathic Myelofibrosis Market Share by Application (2016-2027)
Figure 22. North America Chronic Idiopathic Myelofibrosis Market Share by Country (2016-2027)
Figure 23. United States Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chronic Idiopathic Myelofibrosis Market Share by Type (2016-2027)
Figure 27. Europe Chronic Idiopathic Myelofibrosis Market Share by Application (2016-2027)
Figure 28. Europe Chronic Idiopathic Myelofibrosis Market Share by Country (2016-2027)
Figure 29. Germany Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chronic Idiopathic Myelofibrosis Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Chronic Idiopathic Myelofibrosis Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Chronic Idiopathic Myelofibrosis Market Share by Region (2016-2027)
Figure 39. China Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chronic Idiopathic Myelofibrosis Market Share by Type (2016-2027)
Figure 47. Latin America Chronic Idiopathic Myelofibrosis Market Share by Application (2016-2027)
Figure 48. Latin America Chronic Idiopathic Myelofibrosis Market Share by Country (2016-2027)
Figure 49. Mexico Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chronic Idiopathic Myelofibrosis Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Chronic Idiopathic Myelofibrosis Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Chronic Idiopathic Myelofibrosis Market Share by Country (2016-2027)
Figure 55. Turkey Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Chronic Idiopathic Myelofibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. S-BIO Revenue Growth Rate in Chronic Idiopathic Myelofibrosis Business (2016-2021)
Figure 59. YM BioSciences Revenue Growth Rate in Chronic Idiopathic Myelofibrosis Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Chronic Idiopathic Myelofibrosis Business (2016-2021)
Figure 61. Onyx Pharmaceuticals Revenue Growth Rate in Chronic Idiopathic Myelofibrosis Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

---